Why Tandem Diabetes Care, Inc. (TNDM) stock rose 14.6% on Friday, November 13, 2026
Tandem Diabetes Care, Inc. (TNDM) closed at $20.07, up 14.62% on Friday, November 13, 2026, on volume of 4,395,419 shares (2.0× its 3-month average); market value about $1.40B, according to Nexqual market data (nexqual.com/moves/2026-11-13/TNDM).
What happened: primary sources
Events Nexqual found for TNDM on Friday, November 13, 2026 or the trading day before (November 12, 2026), each linked to its primary source:
- Nov 13, 2026: SEC 8-K: Other material event source
Quoted from the filing: “On November 12, 2026, Tandem Diabetes Care, Inc. (the "Company") received 510(k) clearance from the U.S. Food and Drug Administration for Tandem Mobi, the world's first and only tubeless automated insulin delivery system with up to 7 days of wear (1) . A new Tandem Mobi tubeless cartridge and infusion set converts the current Tandem Mobi pump into a tubeless device that can help simplify diabetes management with less frequent site changes, while offering the life-changing benefits of Control-IQ+ advanced hybrid…”
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on TNDM
TNDM stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 13, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:31 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:31 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt